Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer

Abstract

Non-small cell lung cancer is the predominant form of lung cancer and is associated with a poor prognosis. MiRNAs implicated in cancer initiation and progression can be easily detected in liquid biopsy samples and have the potential to serve as non-invasive biomarkers. In this study, we employed next-generation sequencing to globally profile miRNAs in serum samples from 71 early-stage NSCLC patients and 47 non-cancerous pulmonary condition patients. Preliminary analysis of differentially expressed miRNAs revealed 28 upregulated miRNAs in NSCLC compared to the control group. Functional enrichment analyses unveiled their involvement in NSCLC signaling pathways. Subsequently, we developed a gradient-boosting decision tree classifier based on 2588 miRNAs, which demonstrated high accuracy (0.837), sensitivity (0.806), and specificity (0.859) in effectively distinguishing NSCLC from non-cancerous individuals. Shapley Additive exPlanations analysis improved the model metrics by identifying the top 15 miRNAs with the strongest discriminatory value, yielding an AUC of 0.96 ± 0.04, accuracy of 0.896, sensitivity of 0.884, and specificity of 0.903. Our study establishes the potential utility of a non-invasive serum miRNA signature as a supportive tool for early detection of NSCLC while also shedding light on dysregulated miRNAs in NSCLC biology. For enhanced credibility and understanding, further validation in an independent cohort of patients is warranted.

Six-Gene Signature for Differential Diagnosis and Therapeutic Decisions in Non-Small-Cell Lung Cancer—A Validation Study

“…Additionally, a carefully selected 14-lncRNA signature showed proficiency in detecting NSCLC and classifying subtypes [15]. We also identified a serum-based signature of the top 15 miRNAs, which demonstrated exceptional discriminatory ability [16].…”

Leveraging the Application of IoT based Deep Learning Prediction Model in Smart Healthcare

“…By using this method, deep learning algorithms are able to accurately and precisely sort through vast amounts of clinical data and analyze informational trends and styles. It will be a useful tool for the early diagnosis and detection of pancreatic cancer, enabling earlier identification and maybe greater patient outcomes [12]. Using algorithms to identify features in chest CT images that may indicate the existence of indications of most lung cancers is known as "item detection," and it is used to identify the majority of lung malignancies.…”